Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Primary Care
•
General Primary Care
How do you address patient's concerns for new side effects or decreased efficacy after transitioning from name-brand to generic, or to a new manufacturer for a drug that was already generic?
Related Questions
What are your thoughts about lion's mane supplementation to slow the decline or improve cognitive capacity for those at risk of dementia?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?
Do you have any experience using conolidine supplementation as an adjuvant for pain relief? If so, what brand do you typically recommend?
How do you consider sending fungal studies in a patient with pneumonia?
What is your go-to strategy for non-opioid management of chronic low back pain in patients with limited access to physical therapy or behavioral health?
How do you decide when to initiate antibiotics for superimposed bacterial pneumonia in patients with influenza?
How do you evaluate for an ascending UTI in a patient with a urostomy?
Do you prescribe GLP-1 agonists to diabetic patients admitted with minor CVA or TIA for secondary stroke prevention, as suggested by the LAMP trial?
What is your preferred first line management of alcohol use disorder with concomitant depression?
